This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Oliver Robert Cunningham: Innovator in Pharmaceutical Processes
Introduction
Oliver Robert Cunningham is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative processes. His work has led to the development of a unique patent that showcases his expertise and creativity.
Latest Patents
Cunningham holds a patent for a process titled "Process for the preparation of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-([1-(N-methylcarbamoymethyl)piperidin-4-yl]oxy)quinazoline." This patent describes the processes for the preparation of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline, salts thereof, and the intermediates used in the process. His innovative approach has the potential to impact the pharmaceutical industry significantly.
Career Highlights
Cunningham is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to work on cutting-edge research and development projects. With 1 patent to his name, he has established himself as a valuable contributor to the field.
Collaborations
Throughout his career, Cunningham has collaborated with talented individuals such as Kay Alison Boardman and William Robert Fraser Goundry. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Oliver Robert Cunningham is a distinguished inventor whose work in pharmaceutical processes has made a significant impact. His patent and collaborations reflect his commitment to advancing the field. His contributions will continue to influence the industry for years to come.